Works matching IS 11727047 AND DT 2022 AND VI 36 AND IP 12

Results: 9

Cell Biology of Parkin: Clues to the Development of New Therapeutics for Parkinson's Disease.
Published in:
CNS Drugs, 2022, v. 36, n. 12, p. 1249, doi. 10.1007/s40263-022-00973-7
By:
- Patel, Jaimin;
- Panicker, Nikhil;
- Dawson, Valina L.;
- Dawson, Ted M.
Publication type:
Article
Acknowledgement to Referees.
Published in:
CNS Drugs, 2022, v. 36, n. 12, p. 1243, doi. 10.1007/s40263-022-00972-8
Publication type:
Article
Thromboembolic Risks with Concurrent Direct Oral Anticoagulants and Antiseizure Medications: A Population-Based Analysis.
Published in:
CNS Drugs, 2022, v. 36, n. 12, p. 1313, doi. 10.1007/s40263-022-00971-9
By:
- Ip, Bonaventure Y.;
- Ko, Ho;
- Wong, Grace LH;
- Yip, Terry CF;
- Lau, Louis HS;
- Lau, Alexander YL;
- Leng, Xinyi;
- Leung, Howan;
- Chan, Howard HW;
- Chan, Helen YF;
- Mok, Vincent CT;
- Soo, Yannie OY;
- Leung, Thomas W.
Publication type:
Article
A Multicenter, Randomized, Double-Blind, Positive-Controlled, Non-Inferiority, Phase III Clinical Trial Evaluating the Efficacy and Safety of Emulsified Isoflurane for Anesthesia Induction in Patients.
Published in:
CNS Drugs, 2022, v. 36, n. 12, p. 1301, doi. 10.1007/s40263-022-00970-w
By:
- Yang, Hui;
- Zhang, YuJun;
- Liu, ChuiLiang;
- Ou, YangWen;
- Zhu, YuHang;
- Xue, Yun;
- Zhao, GaoFeng;
- Lin, YuShuang;
- Chen, Chun;
- Xu, GuoHai;
- Yuan, KaiMing;
- Wang, Qiang;
- Zhang, Min;
- Li, LiE;
- Liu, Jin;
- Zhang, WenSheng
Publication type:
Article
Evaluation of a Rapid Topiramate Titration Scheme for the Early Detection of Cognitive Side Effects.
Published in:
CNS Drugs, 2022, v. 36, n. 12, p. 1325, doi. 10.1007/s40263-022-00969-3
By:
- Witt, Juri-Alexander;
- Widman, Guido;
- Hansen, Niels;
- von Wrede, Randi;
- Elger, Christian E.;
- Helmstaedter, Christoph
Publication type:
Article
Authors' Reply to Singh and Balasundaram: Comment on "A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention-Deficit/Hyperactivity Disorder".
Published in:
CNS Drugs, 2022, v. 36, n. 12, p. 1333, doi. 10.1007/s40263-022-00967-5
By:
- Nasser, Azmi;
- Hull, Joseph T.;
- Liranso, Tesfaye;
- Fry, Nicholas;
- Cutler, Andrew J.;
- Rubin, Jonathan;
- Childress, Ann
Publication type:
Article
Comment on: "A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Efficacy and Safety of Viloxazine Extended-Release Capsules in Adults with Attention Deficit/Hyperactivity Disorder".
Published in:
CNS Drugs, 2022, v. 36, n. 12, p. 1331, doi. 10.1007/s40263-022-00966-6
By:
- Singh, Alok;
- Balasundaram, Mahesh Kumar
Publication type:
Article
High-Efficacy Therapies for Treatment-Naïve Individuals with Relapsing–Remitting Multiple Sclerosis.
Published in:
CNS Drugs, 2022, v. 36, n. 12, p. 1285, doi. 10.1007/s40263-022-00965-7
By:
- Freeman, Léorah;
- Longbrake, Erin E.;
- Coyle, Patricia K.;
- Hendin, Barry;
- Vollmer, Timothy
Publication type:
Article
Comparative Effectiveness of Device-Aided Therapies on Quality of Life and Off-Time in Advanced Parkinson's Disease: A Systematic Review and Bayesian Network Meta-analysis.
Published in:
CNS Drugs, 2022, v. 36, n. 12, p. 1269, doi. 10.1007/s40263-022-00963-9
By:
- Antonini, Angelo;
- Pahwa, Rajesh;
- Odin, Per;
- Isaacson, Stuart H.;
- Merola, Aristide;
- Wang, Lin;
- Kandukuri, Prasanna L.;
- Alobaidi, Ali;
- Yan, Connie H.;
- Bao, Yanjun;
- Zadikoff, Cindy;
- Parra, Juan Carlos;
- Bergmann, Lars;
- Chaudhuri, K. Ray
Publication type:
Article